Nemoto Science Co.,Ltd

Corporate profile

FoundedMay 2000
Capital
80,000,000(Yen)
ChainmanIkuyoshi Nemoto
PresidentHiroki Tomisawa Ph.D.
DirectorsKenji Tsuruhara
Akio Morohashi Ph.D.
Hiroki Yonekawa
Mieko Nemoto
Noboru Tonegawa
AuditorAkira Kurabayashi

Head Office

4-10-9 Takaido-Higashi,Suginami-ku,Tokyo 168-0072,Japan

Tsukuba Laboratories

6136-4 Ohnogi-machi,Joso-shi,Ibaraki-ken 300-2521,Japan
TEL:+81-297-24-0781
FAX:+81-297-24-1047

 

TOPへ戻る

Contract research for drug discovery and development

Drug discovery research

Radio-synthesis and purification
In vivo/In vitro phamacokinetic studies

Pre-clinical development (Data Integrity Standards*)

Radio-synthesis and purification
In vivo/in vitro pharmacokinetic studies
Toxicokinetic studies(GLP)

Clinical development (Data Integrity Standards* or GLP**)

Phase Ⅰ-Ⅳ studies
Bioequivalence studies

Stability test (Data Integrity Standards*)

Identification and Assay
performance tests
*Data Integrity Standards:"Data Integrity Standards for Product Application":Japanese regulations
**GLP:Good Laboratory Practice

Competitive Advantage
Well-trained technicians
Competent instruments
Report written in CTD
Use of a variiety of radioisotopes permitted

³H,¹⁴C,²²Na,³²P,³⁵S,⁴⁵Ca,⁵¹Cr,⁵⁷Co,⁵⁹Fe,⁶⁵Zn,⁹⁹Mo-⁹⁹mTc,¹¹⁰mAg,¹¹¹In,¹²³I,¹²⁵I,¹³¹I,¹⁴⁷Pm,¹⁵³Gd
Contract research for drug discovery and development
Contract research for drug discovery and development
Contract research for drug discovery and development
Contract research for drug discovery and development
TOPへ戻る

Contact Us

Tsukuba Laboratories
6136-4 Ohnogo-machi,Joso-shi,Ibaraki-ken 300-2521,Japan

E-mail busi-dep@nemotoscience.co.jp
http://www.nemotoscience.co.jp

TEL:+81-297-24-0781
FAX:+81-297-24-1047

TOPへ戻る